Education
About Us
Working with TipRanks
Follow Us
Ramm Pharma (TSE:RAMM)
:RAMM
| Oct 25 | Jan 25 | Jan 24 | Jan 23 | Jan 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 3.36M | C$ 4.34M | C$ 5.07M | C$ 3.90M | C$ 4.12M |
| Gross Profit | C$ 373.93K | C$ 1.76M | C$ 381.82K | C$ 530.50K | C$ -7.64K |
| Operating Income | C$ -4.52M | C$ -6.76M | C$ -7.09M | C$ -7.93M | C$ -7.19M |
| EBITDA | C$ -3.78M | C$ -15.23M | C$ -6.30M | C$ -19.91M | C$ -6.36M |
| Net Income | C$ -8.91M | C$ -16.50M | C$ -7.72M | C$ -20.96M | C$ -7.11M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 803.88K | C$ 814.04K | C$ 5.12M | C$ 9.77M | C$ 17.16M |
| Total Assets | C$ 9.27M | C$ 16.75M | C$ 32.30M | C$ 39.31M | C$ 59.71M |
| Total Debt | C$ 80.39K | C$ 188.31K | C$ 405.14K | C$ 683.70K | C$ 32.16K |
| Net Debt | C$ -723.49K | C$ -625.73K | C$ -4.71M | C$ -9.09M | C$ -17.12M |
| Total Liabilities | C$ 3.57M | C$ 3.11M | C$ 2.84M | C$ 3.72M | C$ 3.32M |
| Stockholders' Equity | C$ 5.70M | C$ 13.63M | C$ 29.46M | C$ 35.59M | C$ 56.39M |
| Cash Flow | |||||
| Free Cash Flow | C$ -1.06M | C$ -4.05M | C$ -4.45M | C$ -6.08M | C$ -4.25M |
| Operating Cash Flow | C$ -1.06M | C$ -4.00M | C$ -4.34M | C$ -5.91M | C$ -3.82M |
| Investing Cash Flow | C$ 1.22M | C$ -47.43K | C$ 126.58K | C$ -1.15M | C$ -6.83M |
| Financing Cash Flow | C$ -154.07K | C$ -258.23K | C$ -409.97K | C$ -353.77K | C$ -190.33K |
Ramm Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.